iSpecimen Inc. Amortization of Debt Discount (Premium)
iSpecimen Inc. (ISPC) reported Amortization of Debt Discount (Premium) of $869.60 thousand for the 12-month period ending 2021-12-31, per its 10-K/A filed 2023-03-30.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2023-03-30
- iSpecimen Inc. amortization of debt discount (premium) for fiscal 2021 was $869.60K.
| Period end | Amortization of Debt Discount (Premium) 12 month |
|---|---|
| 2021-12-31 | $869.60K 10-K/A · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |